-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
【Chemical Machinery and Equipment Network Star Enterprise】On November 16, CTI announced that the company, as the transferee, and all shareholders of Weisibo jointly signed the "Equity Transfer Agreement on Weisibo Testing Technology (Hefei) Co.
, Ltd.
", and the company acquired 100% of the equity of Weisibo for 163 million yuan (the final transaction price is subject to the exchange rate at the time of actual payment).
Wan Jun holds 2.
25% of the equity of the target company, as one of the counterparties in this transaction, is the brother of Wan Feng, the actual controller of the company, and according to the provisions of the Rules for the Listing of Stocks on the Growth Enterprise Market of the Shenzhen Stock Exchange, Wan Jun is an affiliated natural person
of the company.
The amount of related party transactions involved in this acquisition is 2,804,500 yuan, which is within
the approval authority of the company's board of directors.
, Ltd.
", and the company acquired 100% of the equity of Weisibo for 163 million yuan (the final transaction price is subject to the exchange rate at the time of actual payment).
Wan Jun holds 2.
25% of the equity of the target company, as one of the counterparties in this transaction, is the brother of Wan Feng, the actual controller of the company, and according to the provisions of the Rules for the Listing of Stocks on the Growth Enterprise Market of the Shenzhen Stock Exchange, Wan Jun is an affiliated natural person
of the company.
The amount of related party transactions involved in this acquisition is 2,804,500 yuan, which is within
the approval authority of the company's board of directors.
The transferor's employee shareholding platform will all exit after this transaction, and the company intends to set up a new employee shareholding platform, and the core management/technical team of Weisibo will re-enter the shares
.
The Company will jointly subscribe for the new registered capital of Weisibo at the same price with the employee shareholding platform, and the valuation of the capital increase is mainly based on
the total transaction consideration expected to be paid for the purchase of 100% of the equity of Weisibo.
The company intends to increase its capital to Weisibo by RMB 20,000,000, mainly to repay interest-bearing liabilities and supplement working capital, and the employee shareholding platform intends to increase the proportion of capital to Weisibo with its own funds not exceeding 5%.
After the completion of the capital increase, the company's shareholding ratio will be changed from 100% to not less than 95%.
.
The Company will jointly subscribe for the new registered capital of Weisibo at the same price with the employee shareholding platform, and the valuation of the capital increase is mainly based on
the total transaction consideration expected to be paid for the purchase of 100% of the equity of Weisibo.
The company intends to increase its capital to Weisibo by RMB 20,000,000, mainly to repay interest-bearing liabilities and supplement working capital, and the employee shareholding platform intends to increase the proportion of capital to Weisibo with its own funds not exceeding 5%.
After the completion of the capital increase, the company's shareholding ratio will be changed from 100% to not less than 95%.
Under the macro background of accelerating the localization of the semiconductor industry chain, the semiconductor chip testing industry is prosperous, the market demand is strong, and there are good development prospects
.
Weisibo is a third-party testing company engaged in reliability verification (RA), electrostatic protection capability test (ESD), failure analysis (FA), IC circuit repair (FIB) and other consumer electronic product verification services, with laboratory network layout in Hefei, Shanghai, Taiwan and other places, with professional teams and cutting-edge equipment, deep technical accumulation in the field of integrated circuit testing, ranking in the forefront of the industry and having a strong competitive advantage
.
.
Weisibo is a third-party testing company engaged in reliability verification (RA), electrostatic protection capability test (ESD), failure analysis (FA), IC circuit repair (FIB) and other consumer electronic product verification services, with laboratory network layout in Hefei, Shanghai, Taiwan and other places, with professional teams and cutting-edge equipment, deep technical accumulation in the field of integrated circuit testing, ranking in the forefront of the industry and having a strong competitive advantage
.
CTI has previously laid out in the field of semiconductor testing, with certain talents, technology and management reserves, and the acquisition of Weisibo can further enhance the company's market share and industry position in the semiconductor testing field, which is in line with the company's long-term development strategy
.
After the completion of the transaction, the company will develop and expand Weisibo through a series of measures such as resource introduction and complementary advantages, and help the vigorous development
of China's semiconductor industry.
.
After the completion of the transaction, the company will develop and expand Weisibo through a series of measures such as resource introduction and complementary advantages, and help the vigorous development
of China's semiconductor industry.
